1.60
price up icon3.23%   0.05
after-market Dopo l'orario di chiusura: 1.60
loading

Aytu Biopharma Inc Azioni (AYTU) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
21.54%
17.99
22.93 22.10 30.73 22.73
Cost Of Revenue
6.40%
6.30
6.731 7.315 12.17 9.99
Gross Profit
27.83%
11.69
16.20 14.78 18.56 12.74
Operating Expenses
2.30%
14.16
13.84 16.29 18.39 21.30
Benefits Costs and Expenses
7.57%
20.64
22.33 30.22 33.19 29.93
Costs And Expenses
7.57%
20.64
22.33 30.22 33.19 29.93
Depreciation and Amortization
3.42%
1.834
1.899 1.941 - -
Operating Income/Loss
204.23%
-2.464
2.364 -1.504 0.169 -8.558
Income/Loss From Continuing Operations Before Tax
534.54%
-2.642
0.608 -8.12 -2.457 -7.20
Income Tax Expense/Benefit
70.41%
0.245
0.828 - - -
Income/Loss From Continuing Operations After Tax
1,212%
-2.887
-0.22 -8.12 -2.457 -7.20
Net Income/Loss
1,212%
-2.887
-0.22 -8.12 -2.457 -7.20
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.29%
5.5336
5.5177 5.482 0.2408 3.7268
Basic Earnings Per Share
1,200%
-0.52
-0.04 -1.48 -0.40 -1.93
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$76.22
price down icon 0.79%
$13.45
price down icon 3.79%
$82.47
price down icon 1.14%
$58.78
price down icon 0.54%
$117.62
price up icon 0.15%
$13.00
price up icon 1.33%
Capitalizzazione:     |  Volume (24 ore):